SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

RIPB regulations: Are we there yet?

July 9, 2024, 12:00PMANS News

The latest in the series of ANS Community of Practice (CoP) presentations on risk-informed, performance-based (RIPB) principles, held May 31, 2024, was a departure from past presentations....